arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Computer Science · Artificial Intelligence

Escalating Dose of Mitoxantrone With High-Dose Cyclophosphamide, Carmustine, and Etoposide in Patients With Refractory Lymphoma Undergoing

Autologous Bone, Marrow Transplantation, Michel Attal Pierre Canal, Catherine Payen, Jacques Pris, Guy Laurent

See on the map

Abstract

Purpose: We conducted a dose-finding study of mi-toxantrone (MITO) in combination with high-dose cyclo-phosphamide, carmustine (BCNU), and etoposide (CBV) in refractory lymphoma undergoing autologous bone marrow transplantation (ABMT). The objectives were to determine the following: (1) the maximum-tolerated dose of MITO, (2) the extramedullary toxicity of this regi-men, (3) its antitumor activity, and (4) the pharmacoki-netic characteristics of MITO at each dose level. Patients and Methods: Escalating doses of MITO (15 to 90 mg/m', single bolus infusion on day-8) followed by CBV were administered to 20 patients (mean age, 38.5 years) with refractory lymphoma. MITO concentra-tions were determined by high-performance liquid chro-matography (HPLC).

More like this